Literature DB >> 10531364

Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control.

J M English1, G Pearson, T Hockenberry, L Shivakumar, M A White, M H Cobb.   

Abstract

The activity of the catalytic domain of the orphan MAP kinase ERK5 is increased by Ras but not Raf-1 in cells, which suggests that ERK5 might mediate Raf-independent signaling by Ras. We found that Raf-1 does contribute to Ras activation of ERK5 but in a manner that does not correlate with Raf-1 catalytic activity. A clue to the mechanism of action of Raf-1 on ERK5 comes from the observation that endogenous Raf-1 binds to endogenous ERK5, suggesting the involvement of regulatory protein-protein interactions. This interaction is specific because Raf-1 binds only to ERK5 and not ERK2 or SAPK. Finally, we demonstrate the ERK5/MEK5 pathway is required for Raf-dependent cellular transformation and that a constitutively active form of MEK5, MEK5DD, synergizes with Raf to transform NIH 3T3 cells. These observations suggest that ERK5 plays a large role in Raf-1-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531364     DOI: 10.1074/jbc.274.44.31588

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

Authors:  G Pearson; J M English; M A White; M H Cobb
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 2.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.

Authors:  Matthew S Squires; Paula M Nixon; Simon J Cook
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling.

Authors:  Lei Zhang; Ole Gjoerup; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  Can tumor cells proliferate without ERK5?

Authors:  Emanuele Giurisato; Cathy Tournier
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

6.  A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity.

Authors:  M Janulis; N Trakul; G Greene; E M Schaefer; J D Lee; M R Rosner
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Mice Deficient in lysophosphatidic acid acyltransferase delta (Lpaatδ)/acylglycerophosphate acyltransferase 4 (Agpat4) Have Impaired Learning and Memory.

Authors:  Ryan M Bradley; Emily B Mardian; Darin Bloemberg; Juan J Aristizabal Henao; Andrew S Mitchell; Phillip M Marvyn; Katherine A Moes; Ken D Stark; Joe Quadrilatero; Robin E Duncan
Journal:  Mol Cell Biol       Date:  2017-10-27       Impact factor: 4.272

8.  Phosphorylation of MafA is essential for its transcriptional and biological properties.

Authors:  S Benkhelifa; S Provot; E Nabais; A Eychène; G Calothy; M P Felder-Schmittbuhl
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 9.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

10.  Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.

Authors:  Masaaki Hayashi; Sung-Woo Kim; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; E Dale Abel; Brian Eliceiri; Young Yang; Richard J Ulevitch; Jiing-Dwan Lee
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.